Nuevolution is a company dedicated to revolutionize
fragment and HTS based lead discovery by applying its proprietary Chemetics® technologies
enabling unprecedented synthesis and screening power for rapid and cost-efficient identification of drug leads.
the ultimate “convergent” drug discovery technology –
a unique, patent protected fusion of proven wet chemistry and
molecular biology methods producing an unrivaled capacity for synthesis and screening of millions to billions of drug-like molecules in a single test
Nuevolution has demonstrated the power of Chemetics® by identification of highly potent and drug like novel ligands with the potential to address major unmet medical needs across a range of therapeutic areas and target classes. Nuevolutions internal programs focuses on therapeutically important targets within inflammation and oncology.